Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Dionysios Watson"'
Publikováno v:
Pathogens and Immunity, Vol 9, Iss 1 (2024)
There are a growing number of studies linking the composition of the human microbiome to disease states and treatment responses, especially in the context of cancer. This has raised significant interest in developing microbes and microbial products a
Externí odkaz:
https://doaj.org/article/5187d836d96542e293f71375355a2d12
Autor:
Alice Lo, Peter Sims, Defne Bayik, Yadi Zhou, Chihyun Park, Chngjin Hong, Danielle Silver, Dionysios Watson, Tae Hyun Hwang, Feixiong Cheng, Antonio Iavarone, Justin Lathia
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/000be5abe6894e5bac24832329559661
Autor:
Dionysios Watson, Defne Bayik, Adam Lauko, Samuel Sprowls, Gauravi Deshpande, Sarah Wilifford, Katie Troike, Daniel Silver, Sabrina Wang, Juliana Seder, Kristen Kay, Anita Hjelmeland, Justin Lathia
Publikováno v:
Neuro-Oncology. 24:vii286-vii287
Mitochondrial transfer occurs both in stroke (central nervous system) and inflammatory pain (peripheral nerves). However, its role in glioblastoma (GBM) remains poorly understood. We hypothesized that mitochondrial transfer from non-malignant to GBM
Autor:
Defne Bayik, Cynthia Bartels, Katreya Lovrenert, Duo Zhang, Dionysios Watson, Kristen Kay, Juyeun Lee, Michael Vogelbaum, Yi Fan, Peter Scacheri, Justin Lathia
Publikováno v:
Neuro-Oncology. 24:vii134-vii135
Accumulation of various immunosuppressive myeloid cells, including myeloid-derived suppressor cells (MDSCs), facilitates progression and treatment resistance of glioblastoma (GBM). We previous demonstrated that monocytic MDSCs (mMDSCs) but not granul
Autor:
Alireza Mohammadi, Matthew Grabowski, Dionysios Watson, Adam Lauko, Justin Lathia, Manmeet Ahluwalia
Publikováno v:
Neuro-Oncology. 24:vii144-vii144
INTRODUCTION Despite advances in targeted therapy and immunotherapy of many cancers, glioblastoma outcome is still suboptimal in part due to heterogeneity of tumor. Standard surgical approach for glioblastoma is to remove the enhancing tumor and adju